Prosecution Insights
Prosecution Insights
Technology area: Chemistry & Materials
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Cytoaurora Biotechnologies Inc. has 2 pending office actions in the Chemistry & Materials technology area. These matters are being reviewed by 2 distinct examiners. Although there are multiple examiners involved, all current prosecution is occurring within 1 distinct art unit. This indicates that the company's current intellectual property is technically focused enough to stay within 1 distinct art unit, even as it is split between different personnel.
The busiest examiner for the portfolio is HUANG, MICKEY NMN, who is managing 1 pending office action. Given that the total number of 2 pending office actions is split among 2 distinct examiners, the workload is divided. This requires the company to navigate the specific preferences of these individuals within the same Chemistry & Materials art unit. HUANG, MICKEY NMN is responsible for a portion of the active cases.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HUANG, MICKEY NMN | 1 | 59.6% | +49.2% |
| NGUYEN, HENRY H | 1 | 63.7% | +37.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18507075 | BIOPARTICLE ENRICHMENT APPARATUS, BIOPARTICLE ENRICHMENT DEVICE, AND PICO-DROPLET GENERATOR | HUANG, MICKEY NMN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18132485 | BIOLOGICAL PARTICLE ANALYSIS METHOD | NGUYEN, HENRY H | 82d |
| 18507075 | BIOPARTICLE ENRICHMENT APPARATUS, BIOPARTICLE ENRICHMENT DEVICE, AND PICO-DROPLET GENERATOR | HUANG, MICKEY NMN | — |
| Art Unit | Apps |
|---|---|
| 1758 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18507075 | BIOPARTICLE ENRICHMENT APPARATUS, BIOPARTICLE ENRICHMENT DEVICE, AND PICO-DROPLET GENERATOR | HUANG, MICKEY NMN | 1758 | §102§103 | Non-Final OA | — | Pending | Nov 12, 2023 |
| 18132485 | BIOLOGICAL PARTICLE ANALYSIS METHOD | NGUYEN, HENRY H | 1758 | §103 | Final Rejection | 82d | Pending | Apr 10, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial